FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204182287> ?p ?o ?g. }

• W3204182287 abstract "Circulating soluble programmed death-1 ligand (sPD-L1) is measurable in the serum of cancer patients. This study aimed to investigate the significance of sPD-L1 in cancer patients receiving immune checkpoint inhibitor therapy. Blood samples were obtained before and after immune checkpoint inhibitor therapy (January 2015 to January 2019). The study cohort consisted of 128 patients who were diagnosed with non-small cell lung cancer (n = 50), melanoma (n = 31), small cell lung cancer (n = 14), urothelial carcinoma (n = 13), and other cancers (n = 20). Patients with a high level (> 11.0 pg/μL) of sPD-L1 were more likely to exhibit progressive disease compared with those with a low level (41.8% versus 20.7%, p = 0.013). High sPD-L1 was also associated with worse prognosis; the median PFS was 2.9 (95% confidence interval [CI] 2.1-3.7) months versus 6.3 (95% CI 3.0-9.6) months (p = 0.023), and the median OS was 7.4 (95% CI 6.3-8.5) months versus 13.3 (95% CI 9.2-17.4) months (p = 0.005). In the multivariate analyses, high sPD-L1 was an independent prognostic factor for both decreased PFS (HR 1.928, p = 0.038) and OS (HR 1.788, p = 0.004). sPD-L1 levels did not correlate with tissue PD-L1 expression. However, sPD-L1 levels were positively correlated with neutrophil to lymphocyte ratios and negatively correlated with both the proportion and the total number of lymphocytes. We found that high pretreatment sPD-L1 levels were associated with progressive disease and were an independent prognostic factor predicting lower PFS and OS in these patients." @default.
• W3204182287 created "2021-10-11" @default.
• W3204182287 creator A5019037704 @default.
• W3204182287 creator A5020952516 @default.
• W3204182287 creator A5024891671 @default.
• W3204182287 creator A5042401127 @default.
• W3204182287 creator A5058521062 @default.
• W3204182287 creator A5059849795 @default.
• W3204182287 date "2021-10-05" @default.
• W3204182287 modified "2023-10-13" @default.
• W3204182287 title "Soluble PD-L1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatment" @default.
• W3204182287 cites W1811917379 @default.
• W3204182287 cites W1978857579 @default.
• W3204182287 cites W1992569798 @default.
• W3204182287 cites W2036464787 @default.
• W3204182287 cites W2048974336 @default.
• W3204182287 cites W2073125824 @default.
• W3204182287 cites W2104347254 @default.
• W3204182287 cites W2145758395 @default.
• W3204182287 cites W2198093519 @default.
• W3204182287 cites W2210073947 @default.
• W3204182287 cites W2324094374 @default.
• W3204182287 cites W2506616866 @default.
• W3204182287 cites W2507710416 @default.
• W3204182287 cites W2522277066 @default.
• W3204182287 cites W2557730509 @default.
• W3204182287 cites W2559826815 @default.
• W3204182287 cites W2588072686 @default.
• W3204182287 cites W2589148013 @default.
• W3204182287 cites W2594102731 @default.
• W3204182287 cites W2615907969 @default.
• W3204182287 cites W2618077299 @default.
• W3204182287 cites W2623388110 @default.
• W3204182287 cites W2703678370 @default.
• W3204182287 cites W2775456764 @default.
• W3204182287 cites W2789588846 @default.
• W3204182287 cites W2797075366 @default.
• W3204182287 cites W2807333298 @default.
• W3204182287 cites W2887292684 @default.
• W3204182287 cites W2902865813 @default.
• W3204182287 cites W2903582814 @default.
• W3204182287 cites W2904030185 @default.
• W3204182287 cites W2905213061 @default.
• W3204182287 cites W2913496992 @default.
• W3204182287 cites W2915789992 @default.
• W3204182287 cites W2915944698 @default.
• W3204182287 cites W2921052875 @default.
• W3204182287 cites W2921582687 @default.
• W3204182287 cites W2947830465 @default.
• W3204182287 cites W2957229748 @default.
• W3204182287 cites W2964248103 @default.
• W3204182287 cites W2965462776 @default.
• W3204182287 cites W2970916519 @default.
• W3204182287 cites W2972873235 @default.
• W3204182287 cites W2973146617 @default.
• W3204182287 cites W2988002600 @default.
• W3204182287 cites W2990052644 @default.
• W3204182287 cites W2997348972 @default.
• W3204182287 cites W3000685958 @default.
• W3204182287 cites W3030278232 @default.
• W3204182287 cites W3046843647 @default.
• W3204182287 cites W634312238 @default.
• W3204182287 doi "https://doi.org/10.1038/s41598-021-99311-y" @default.
• W3204182287 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8492653" @default.
• W3204182287 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34611279" @default.
• W3204182287 hasPublicationYear "2021" @default.
• W3204182287 type Work @default.
• W3204182287 sameAs 3204182287 @default.
• W3204182287 citedByCount "42" @default.
• W3204182287 countsByYear W32041822872022 @default.
• W3204182287 countsByYear W32041822872023 @default.
• W3204182287 crossrefType "journal-article" @default.
• W3204182287 hasAuthorship W3204182287A5019037704 @default.
• W3204182287 hasAuthorship W3204182287A5020952516 @default.
• W3204182287 hasAuthorship W3204182287A5024891671 @default.
• W3204182287 hasAuthorship W3204182287A5042401127 @default.
• W3204182287 hasAuthorship W3204182287A5058521062 @default.
• W3204182287 hasAuthorship W3204182287A5059849795 @default.
• W3204182287 hasBestOaLocation W32041822871 @default.
• W3204182287 hasConcept C121608353 @default.
• W3204182287 hasConcept C126322002 @default.
• W3204182287 hasConcept C143998085 @default.
• W3204182287 hasConcept C170493617 @default.
• W3204182287 hasConcept C207103383 @default.
• W3204182287 hasConcept C2776256026 @default.
• W3204182287 hasConcept C2777658100 @default.
• W3204182287 hasConcept C2777701055 @default.
• W3204182287 hasConcept C2778468042 @default.
• W3204182287 hasConcept C2780851360 @default.
• W3204182287 hasConcept C2781053074 @default.
• W3204182287 hasConcept C2781197716 @default.
• W3204182287 hasConcept C44249647 @default.
• W3204182287 hasConcept C502942594 @default.
• W3204182287 hasConcept C55493867 @default.
• W3204182287 hasConcept C71924100 @default.
• W3204182287 hasConcept C86803240 @default.
• W3204182287 hasConcept C90924648 @default.
• W3204182287 hasConceptScore W3204182287C121608353 @default.
• W3204182287 hasConceptScore W3204182287C126322002 @default.
• W3204182287 hasConceptScore W3204182287C143998085 @default.

• next